MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration

AS Harms, S Cao, AL Rowse, AD Thome… - Journal of …, 2013 - Soc Neuroscience
Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

AS Harms, S Cao, AL Rowse, AD Thome… - Journal of …, 2013 - Soc Neuroscience
Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration

AS Harms, S Cao, AL Rowse… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

[HTML][HTML] MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

AS Harms, S Cao, AL Rowse, AD Thome… - The Journal of …, 2013 - ncbi.nlm.nih.gov
Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

[PDF][PDF] MHCII Is Required forα-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

AS Harms, S Cao, AL Rowse, AD Thome… - The Journal of …, 2013 - academia.edu
Accumulation ofα-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

[PDF][PDF] MHCII Is Required forα-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

AS Harms, S Cao, AL Rowse, AD Thome… - The Journal of …, 2013 - researchgate.net
Accumulation ofα-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

[引用][C] MHCII Is Required for-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

AS Harms, S Cao, AL Rowse, AD Thome, X Li… - Journal of …, 2013 - cir.nii.ac.jp
MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation,
and Dopaminergic Neurodegeneration | CiNii Research CiNii 国立情報学研究所 学術情報 …

MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.

AS Harms, S Cao, AL Rowse, AD Thome… - The Journal of …, 2013 - europepmc.org
Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …

MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.

AS Harms, S Cao, AL Rowse, AD Thome… - The Journal of …, 2013 - europepmc.org
Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD)
and leads to microglial activation, production of inflammatory cytokines and chemokines, T …